Becton, Dickinson and Company (BDX) Receives FDA Clearance for New Breast Biopsy System, Expected Market Launch in 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 15 2026
0mins
Should l Buy BDX?
Source: Benzinga
- FDA Approval: The U.S. FDA granted clearance for Becton, Dickinson and Company's EnCor EnCompass Breast Biopsy and Tissue Removal System, expected to launch in early 2026, enhancing the biopsy experience across various imaging modalities and strengthening market competitiveness.
- Stable Market Valuation: BDX maintains a market capitalization of $59.10 billion, with a 52-week stock range of $162.29 to $251.99, reflecting robust performance in the medical device sector and aligning with broader market trends, indicating investor confidence in future growth.
- Positive Technical Indicators: BDX's Relative Strength Index (RSI) stands at 66.21, indicating neutral to bullish momentum, while a MACD of 2.94 suggests strong price momentum, potentially providing a favorable entry point for investors.
- Earnings Forecast: Analysts project earnings per share of $2.82, down from $3.43 last year, with revenue slightly decreasing to $5.15 billion; however, the consensus Buy rating and an average price target of $245.93 reflect optimism about the company's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BDX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BDX
Wall Street analysts forecast BDX stock price to rise
11 Analyst Rating
5 Buy
6 Hold
0 Sell
Moderate Buy
Current: 157.230
Low
157.00
Averages
192.64
High
232.00
Current: 157.230
Low
157.00
Averages
192.64
High
232.00
About BDX
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. It operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BD Launches Advanced Medication Management Solutions in Europe
- Medication Management Innovation: BD's newly launched BD® Pyxis™ Pro dispensing solution integrates advanced automation and artificial intelligence to enhance medication management efficiency, reducing interruptions and allowing healthcare professionals to dedicate more time to patient care.
- Flexible Storage Capacity: The system's stackable design increases medication storage capacity, enabling hospitals and healthcare systems to adapt to changing patient needs, ensuring rapid and secure access to medications, thereby improving the quality of patient care.
- Data Analytics Platform Expansion: BD is extending its AI-based BD Incada™ Analytics platform to Europe, leveraging AWS cloud infrastructure to manage data generated by nearly three million smart devices, assisting healthcare professionals in optimizing medication inventory management and reducing waste.
- Multilingual Support: The BD® Pyxis™ Pro solution will be fully operational across Europe in the coming months, supporting 15 languages, further enhancing its adaptability and competitiveness in the international market.
See More
BD Launches New Drug Distribution Solutions in Europe
- New Drug Distribution System: BD's newly launched BD®Pyxis™ Pro system integrates advanced automation and AI insights to enhance medication management efficiency, reduce interruptions, and allow clinicians to focus more on patient care, thereby improving overall healthcare service quality.
- Increased Storage Capacity: The system's flexible, stackable design offers superior medication storage capacity, adapting to hospitals' evolving needs for medication availability, which in turn enhances operational efficiency and patient satisfaction.
- Analytics Platform Expansion: BD plans to launch the BD®Incada™ Analytics platform in Europe next year, leveraging AWS cloud infrastructure to support data analysis from nearly three million smart devices, enabling clinicians to monitor medication inventory in real-time, reduce waste, and improve workforce efficiency.
- Multilingual Support: The BD®Pyxis™ Pro system will support deployment in 15 languages over the coming months, further enhancing its adaptability and availability in the European market to meet the diverse needs of hospitals across different regions.
See More
BD Launches New Medication Management Solutions in Europe
- Medication Management Innovation: BD's introduction of the BD®Pyxis™ Pro Dispensing Solution integrates advanced automation with AI insights to enhance medication management efficiency and reduce disruptions, thereby allowing healthcare professionals to focus more on patient care, which is expected to significantly improve hospital medication supply chain management.
- Enhanced Safety Features: The new system improves the management of controlled substances through features like RFID scanning, wireless barcode scanners, and illuminated shelves, ensuring traceability of medications and helping hospitals better adapt to changing patient needs.
- Data Analytics Platform Expansion: BD plans to roll out its AI-driven BD Incada™ Analytics platform to the European market within the next year, leveraging AWS cloud infrastructure to handle data from nearly three million devices, enhancing healthcare institutions' real-time monitoring capabilities of medication inventories.
- Support for Digital Sovereignty: BD will utilize the AWS European Sovereign Cloud in the European market to assist EU health systems in meeting digital sovereignty requirements while maintaining high performance and innovation capabilities, further driving the digital transformation of healthcare services.
See More
BD Launches Next-Gen Medication Dispensing Solutions in Europe
- Medication Management Innovation: BD's launch of the BD®Pyxis™ Pro Dispensing Solution integrates advanced automation and AI-driven insights to modernize medication management, reduce disruptions, and enhance efficiency, thereby allowing clinicians to dedicate more time to patient care.
- Flexible Storage Configuration: The system's flexible, stackable device configuration offers greater medication storage capacity within a similar footprint, improving medication availability and enabling hospitals and health systems to adapt to the evolving needs of their patient populations, ultimately enhancing overall healthcare service quality.
- AI Analytics Platform Expansion: BD plans to extend its BD®Incada™ Analytics platform to European hospitals next year, leveraging AWS cloud infrastructure to provide enterprise-wide visibility into medication inventory, helping clinicians identify patterns and ensure medication availability.
- Digital Sovereignty Support: BD will utilize the AWS European Sovereign Cloud in the European market to ensure EU healthcare systems meet their digital sovereignty needs without compromising on performance, innovation, security, or scale, further driving the digital transformation of the healthcare industry.
See More
BD Launches Next-Gen Medication Management Solutions in Europe
- Medication Management Innovation: BD's launch of the BD®Pyxis™ Pro Dispensing Solution integrates advanced automation with AI-driven insights to enhance medication management efficiency and reduce disruptions, thereby allowing clinicians to focus more on patient care.
- Increased Storage Capacity: The system's flexible, stackable configuration offers greater medication storage capacity within a similar footprint, improving medication availability and helping hospitals adapt to the evolving needs of their patient populations, thus enhancing overall healthcare service capabilities.
- AI Analytics Platform Expansion: BD plans to extend the BD®Incada™ Connected Care Platform to European hospitals next year, leveraging AWS cloud infrastructure to provide enterprise-wide visibility into medication inventory, helping clinicians identify patterns, reduce medication waste, and improve labor efficiency.
- Multilingual Support: The Pyxis™ Pro Dispensing Solution will roll out with support for 15 languages in the coming months, further strengthening BD's competitive position in the European market and ensuring its solutions meet diverse customer needs.
See More
BD Launches Next-Gen Medication Management Solutions in Europe
- Medication Management Innovation: BD's launch of the BD® Pyxis™ Pro Dispensing Solution integrates advanced automation and AI-driven insights to enhance medication management efficiency, reduce disruptions, and allow clinicians to focus more on patient care.
- Increased Storage Capacity: The system's flexible, stackable design offers greater medication storage capacity within a similar footprint, improving medication availability and helping hospitals adapt to the evolving needs of their patient populations, thereby enhancing overall healthcare service quality.
- Analytics Platform Expansion: BD will extend the BD® Incada™ Connected Care Platform to Europe next year, leveraging AWS cloud infrastructure to provide enterprise-wide visibility into medication inventory, helping clinicians identify patterns, reduce medication waste, and improve labor efficiency.
- Enhanced Security Features: The new system improves controlled substance management efficiency through features like RFID badge scanning, wireless barcode scanners, and illuminated bins, ensuring secure access to medications and further improving patient care quality.
See More
BD Launches Advanced Medication Management Solutions in Europe
- Medication Management Innovation: BD's newly launched BD® Pyxis™ Pro dispensing solution integrates advanced automation and artificial intelligence to enhance medication management efficiency, reducing interruptions and allowing healthcare professionals to dedicate more time to patient care.
- Flexible Storage Capacity: The system's stackable design increases medication storage capacity, enabling hospitals and healthcare systems to adapt to changing patient needs, ensuring rapid and secure access to medications, thereby improving the quality of patient care.
- Data Analytics Platform Expansion: BD is extending its AI-based BD Incada™ Analytics platform to Europe, leveraging AWS cloud infrastructure to manage data generated by nearly three million smart devices, assisting healthcare professionals in optimizing medication inventory management and reducing waste.
- Multilingual Support: The BD® Pyxis™ Pro solution will be fully operational across Europe in the coming months, supporting 15 languages, further enhancing its adaptability and competitiveness in the international market.
See More
BD Launches New Drug Distribution Solutions in Europe
- New Drug Distribution System: BD's newly launched BD®Pyxis™ Pro system integrates advanced automation and AI insights to enhance medication management efficiency, reduce interruptions, and allow clinicians to focus more on patient care, thereby improving overall healthcare service quality.
- Increased Storage Capacity: The system's flexible, stackable design offers superior medication storage capacity, adapting to hospitals' evolving needs for medication availability, which in turn enhances operational efficiency and patient satisfaction.
- Analytics Platform Expansion: BD plans to launch the BD®Incada™ Analytics platform in Europe next year, leveraging AWS cloud infrastructure to support data analysis from nearly three million smart devices, enabling clinicians to monitor medication inventory in real-time, reduce waste, and improve workforce efficiency.
- Multilingual Support: The BD®Pyxis™ Pro system will support deployment in 15 languages over the coming months, further enhancing its adaptability and availability in the European market to meet the diverse needs of hospitals across different regions.
See More
BD Launches New Medication Management Solutions in Europe
- Medication Management Innovation: BD's introduction of the BD®Pyxis™ Pro Dispensing Solution integrates advanced automation with AI insights to enhance medication management efficiency and reduce disruptions, thereby allowing healthcare professionals to focus more on patient care, which is expected to significantly improve hospital medication supply chain management.
- Enhanced Safety Features: The new system improves the management of controlled substances through features like RFID scanning, wireless barcode scanners, and illuminated shelves, ensuring traceability of medications and helping hospitals better adapt to changing patient needs.
- Data Analytics Platform Expansion: BD plans to roll out its AI-driven BD Incada™ Analytics platform to the European market within the next year, leveraging AWS cloud infrastructure to handle data from nearly three million devices, enhancing healthcare institutions' real-time monitoring capabilities of medication inventories.
- Support for Digital Sovereignty: BD will utilize the AWS European Sovereign Cloud in the European market to assist EU health systems in meeting digital sovereignty requirements while maintaining high performance and innovation capabilities, further driving the digital transformation of healthcare services.
See More
BD Launches Next-Gen Medication Dispensing Solutions in Europe
- Medication Management Innovation: BD's launch of the BD®Pyxis™ Pro Dispensing Solution integrates advanced automation and AI-driven insights to modernize medication management, reduce disruptions, and enhance efficiency, thereby allowing clinicians to dedicate more time to patient care.
- Flexible Storage Configuration: The system's flexible, stackable device configuration offers greater medication storage capacity within a similar footprint, improving medication availability and enabling hospitals and health systems to adapt to the evolving needs of their patient populations, ultimately enhancing overall healthcare service quality.
- AI Analytics Platform Expansion: BD plans to extend its BD®Incada™ Analytics platform to European hospitals next year, leveraging AWS cloud infrastructure to provide enterprise-wide visibility into medication inventory, helping clinicians identify patterns and ensure medication availability.
- Digital Sovereignty Support: BD will utilize the AWS European Sovereign Cloud in the European market to ensure EU healthcare systems meet their digital sovereignty needs without compromising on performance, innovation, security, or scale, further driving the digital transformation of the healthcare industry.
See More
BD Launches Next-Gen Medication Management Solutions in Europe
- Medication Management Innovation: BD's launch of the BD®Pyxis™ Pro Dispensing Solution integrates advanced automation with AI-driven insights to enhance medication management efficiency and reduce disruptions, thereby allowing clinicians to focus more on patient care.
- Increased Storage Capacity: The system's flexible, stackable configuration offers greater medication storage capacity within a similar footprint, improving medication availability and helping hospitals adapt to the evolving needs of their patient populations, thus enhancing overall healthcare service capabilities.
- AI Analytics Platform Expansion: BD plans to extend the BD®Incada™ Connected Care Platform to European hospitals next year, leveraging AWS cloud infrastructure to provide enterprise-wide visibility into medication inventory, helping clinicians identify patterns, reduce medication waste, and improve labor efficiency.
- Multilingual Support: The Pyxis™ Pro Dispensing Solution will roll out with support for 15 languages in the coming months, further strengthening BD's competitive position in the European market and ensuring its solutions meet diverse customer needs.
See More
BD Launches Next-Gen Medication Management Solutions in Europe
- Medication Management Innovation: BD's launch of the BD® Pyxis™ Pro Dispensing Solution integrates advanced automation and AI-driven insights to enhance medication management efficiency, reduce disruptions, and allow clinicians to focus more on patient care.
- Increased Storage Capacity: The system's flexible, stackable design offers greater medication storage capacity within a similar footprint, improving medication availability and helping hospitals adapt to the evolving needs of their patient populations, thereby enhancing overall healthcare service quality.
- Analytics Platform Expansion: BD will extend the BD® Incada™ Connected Care Platform to Europe next year, leveraging AWS cloud infrastructure to provide enterprise-wide visibility into medication inventory, helping clinicians identify patterns, reduce medication waste, and improve labor efficiency.
- Enhanced Security Features: The new system improves controlled substance management efficiency through features like RFID badge scanning, wireless barcode scanners, and illuminated bins, ensuring secure access to medications and further improving patient care quality.
See More
